Learning Objectives:

 

  1.  Identify what biomarkers should be utilized to detect the most at-risk population, to detect the disease while measurable and yet not clinically apparent?
  2.  identify the most relevant candidate biomarkers of early detection in Thoracic Cancers
  3. Describe critical aspects of study design in molecular biomarkers for early detection of lung cancer
Session date: 
Tuesday, February 21, 2017 - 6:45am to 7:45am
Speaker Name: 
Jussuf Kaifi, MD, PhD
Location: 
UCMC E-500
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.